Validation and Value: The Risk of RNAi Therapeutics
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 80 (Table of Contents)
Published: 7 Feb-2007
DOI: 10.3833/pdr.v2007.i80.393 ISSN: 1756-7874
Section: General
Fulltext:
Abstract
RNAi is invaluable as an R&D and drug discovery tool, and holds great commercial value in identifying new disease targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS